Lanx

About:

Lanx employs its proprietary technology to develop spinal products for surgeons.

Website: http://www.lanx.com

Top Investors: Delta-v Capital, Credit Suisse

Description:

There mission is to improve the quality of care for patients worldwide by providing surgeons with the most innovative spinal products. Lanx was founded in 2003 and is led by a team of experienced medical professionals and engineers. Lanx has created a robust product portfolio with exceptional quality of products. As one of the fastest growing spinal implant companies in the US, Lanx is an emerging leader in spine, uniquely integrating the elements of innovation, vision, and unrivaled personnel all working towards the common goal of improving patient care.

Total Funding Amount:

$16.6M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Broomfield, Colorado, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)lanx.com

Founders:

Jeffrey Thramann

Number of Employees:

251-500

Last Funding Date:

2013-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai